References in this report to we, us, our or the
Company refer to Miromatrix Medical Inc. The following discussion and analysis
of the Company s financial condition and results of operations should be. | November 14, 2022
The company s goal is to eliminate the waiting list for organ transplants by developing bioengineered organs including livers and kidneys for human transplant.